HematoLogics, Inc. is the recognized leader for Measurable Residual Disease Testing for Acute Leukemia.

HematoLogics offers a complete test menu for your MRD needs. In addition to ∆N:(Difference from Normal) Flow Cytometry   and Molecular Genetics, we perform Cytogenetics, FISH, Next Generation Sequencing, and SNP/CGH Microarray, all under one roof. All services are found on the website.


Our Superior Sensitivity is as low as 0.02% with only a 24-48 hour Turn Around Time.
Leader in Residual Disease Testing
HematoLogics, Inc. is the only Lab offering Cell Sorting and Molecular confirmation of small Neoplastic Populations
∆N:™  (Difference from Normal) Flow Cytometry  can identify small changing populations where the traditional Leukemia Associated Immunophenotype (LAIP) may give false negatives
∆N:™  (Difference from Normal) Flow Cytometry validated in clinical trials
∆N:™  (Difference from Normal) Flow Cytometry validated in normal Pediatric and Adult specimens